Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland
Alden A. Moccia(BC Cancer Agency), Felicitas Hitz(Kantonsspital St. Gallen), Thilo Zander(Luzerner Kantonsspital), Michèle Voegeli(Kantonsspital Baselland), Markus F. Rütti(WiLAN (Canada)), Guido Ghilardi(Hospital of the University of Pennsylvania), Fatime Krasniqi(University Hospital of Basel), Ulrich Mey(Kantonsspital Graubünden), Monika Ebnöther(St. Claraspital), Natalie Fischer(Kantonsspital Winterthur), Walter Mingrone(Kantonsschule Olten), Sabine Güsewell(Kantonsspital St. Gallen), Urban Novak(University of Bern), Mario Bargetzi(Kantonsspital Aarau), D. Brülisauer(University Hospital of Bern), Martin Fehr(Kantonsspital St. Gallen), Adrian Schmidt(Triemli Hospital), Frank Stenner(University Hospital of Basel), Emanuele Zucca(Ente Ospedaliero Cantonale), Claudia Pfleger(St. Claraspital), P Richter(Kantonsspital Graubünden), Stefanie Aeppli(Kantonsspital St. Gallen), Clemens B. Caspar(Kantonsspital Baden), Noémie Lang(University Hospital of Geneva)
Cited by 15
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
|The Lancet Oncology|2015|613
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|568
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
|Nature Medicine|2022|308
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
|Nature Medicine|2024|254